Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Nude Mice. Found 21 abstracts

no pagination
Zhao S, Tang H, Yan D, Fan J, Sun H, Wen Y, Yu F, Cui F, Zhang D, Xue Y, Liu C, Yue B, Chen J, Wang J, Wang X, Zhang M, Yu Y, Jiang W, Liu X, Mi Y, Zhou Z, Qin X, Peng Z. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFkappaB/CSN2/GSK-3beta signaling. Oncotarget. 2016 Apr 12;7(15):19794-812.   PMCID: PMC4991419
Allen JE, Prabhu VV, Talekar M, van den Heuvel AP, Lim B, Dicker DT, Fritz JL, Beck A, El-Deiry WS. Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10. Cancer Res. 2015 Apr 15;75(8):1668-74.   PMCID: PMC4541796
Deng XB, Xiao L, Wu Y, Jin F, Mossman B, Testa JR, Xiao GH. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. International journal of cancer. 2015 Jul 15;137(2):481-90.   PMCID: PMC4428975
Kalra N, Zhang J, Thomas A, Xi L, Cheung M, Talarchek J, Burkett S, Tsokos MG, Chen Y, Raffeld M, Miettinen M, Pastan I, Testa JR, Hassan R. Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma. BMC Cancer. 2015 Jan;15:376.   PMCID: PMC4431029
Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK. Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment. Oncogene. 2015 Jan;34(2):144-53.   PMCID: PMC4067476
Rapoport N, Gupta R, Kim YS, O'Neill BE. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging. J Control Release. 2015 May 28;206:153-60.
Sodani K, Patel A, Anreddy N, Singh S, Yang DH, Kathawala RJ, Kumar P, Talele TT, Chen ZS. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical pharmacology. 2014 May;89(1):52-61.   PMCID: Pmc3983711
Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, Delmas V, Larue L. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene. 2013 Apr 25;32(17):2230-8.   PMCID: Pmc3637425
Garipov A, Li H, Bitler BG, Thapa RJ, Balachandran S, Zhang R. NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells. Molecular cancer research : MCR. 2013 Apr;11(4):360-9.   PMCID: PMC3631279
Hensley HH, Hannoun-Levi JM, Hachem P, Mu Z, Stoyanova R, Khor LY, Agrawal S, Pollack A. PKA knockdown enhances cell killing in response to radiation and androgen deprivation. International journal of cancer. 2011 Feb 15;128(4):962-73.   PMCID: NIHMS236076
Patel RR, Sengupta S, Kim HR, Klein-Szanto AJ, Pyle JR, Zhu F, Li T, Ross EA, Oseni S, Fargnoli J, Jordan VC. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitors. Eur J Cancer. 2010 Jun;46(9):1537-53.   PMCID: PMC2927957
Mu Z, Hachem P, Hensley H, Stoyanova R, Kwon HW, Hanlon AL, Agrawal S, Pollack A. Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo. The Prostate. 2008 May;68(6):599-609.
Robinson MK, Shaller C, Garmestani K, Plascjak PS, Hodge KM, Yuan QA, Marks JD, Waldmann TA, Brechbiel MW, Adams GP. Effective treatment of established human breast tumor xenografts in immunodeficient mice with a single dose of the alpha-emitting radioisotope astatine-211 conjugated to anti-HER2/neu diabodies. Clin Cancer Res. 2008 Feb;14(3):875-82.   PMCID: PMC2643368
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Ruggeri BA, Robinson C, Angeles T, Wilkinson Jt, Clapper ML. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. Clin Cancer Res. 2002 Jan;8(1):267-74.
Takahashi N, Li W, Banerjee D, Guan Y, Wada-Takahashi Y, Brennan MF, Chou TC, Scotto KW, Bertino JR. Sequence-dependent synergistic cytotoxicity of ET-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo. Cancer Res. 2002 Dec;62(23):6909-15.
Gabrielson EW, Pinn ML, Testa JR, Kuhajda FP. Increased fatty acid synthase is a therapeutic target in mesothelioma. Clin Cancer Res. 2001 Jan;7(1):153-7.
Watson JC, Balster DA, Gebhardt BM, O'Dorisio TM, O'Dorisio MS, Espenan GD, Drouant GJ, Woltering EA. Growing vascular endothelial cells express somatostatin subtype 2 receptors. Br J Cancer. 2001 Jul 20;85(2):266-72.
Adams GP, Shaller CC, Chappell LL, Wu C, Horak EM, Simmons HH, Litwin S, Marks JD, Weiner LM, Brechbiel MW. Delivery of the alpha-emitting radioisotope bismuth-213 to solid tumors via single-chain Fv and diabody molecules. Nucl Med Biol. 2000 May;27(4):339-46.
Chen SH, Qian M, Brennan JM, Gallo JM. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. J Chromatogr B Biomed Sci Appl. 1997 Apr 25;692(1):43-51.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Nude Mice

Nude Mice Mice metabolism genetics pathology Female Male Tumor Cell Line therapeutic use drug effects drug therapy Animal Xenograft Model Antitumor Assays physiology US Gov't Support-PHS pharmacology Non-US Gov't Support Heterologous Transplantation Cell Proliferation administration & dosage Cultured Tumor Cells Breast Neoplasms Human Apoptosis Neoplasm Transplantation Lung Neoplasms antagonists & inhibitors Tissue Distribution Radioimmunotherapy Antineoplastic Agents Ovarian Neoplasms Western Blotting Antineoplastic Combined Chemotherapy Protocols Mesothelioma SCID Mice HCT116 Cells Disease Progression radiotherapy blood supply Immunoenzyme Techniques enzymology Paclitaxel analogs & derivatives Angiogenesis Inhibitors Middle Aged Hepatocyte Growth Factor Reverse Transcriptase Polymerase Chain Reaction Antisense Oligonucleotides Drug Dose-Response Relationship Cell Movement Prostatic Neoplasms Androgen Antagonists biosynthesis Androgen Receptors erbB-2 Receptor cytology Cultured Cells Neoplasm Drug Resistance methods beta Catenin Fluorouracil Random Allocation Neoplastic Gene Expression Regulation Inbred BALB C Mice Vascular Endothelium US Gov't Support-Non-PHS Immunohistochemistry Aged Proto-Oncogene Proteins c-met Experimental Neoplasms Signal Transduction Orchiectomy Fatty Acid Synthetase Complex Melanoma im [Immunology] Androgens Glycogen Synthase Kinase 3 beta Antifungal Antibiotics Vascular Endothelial Growth Factor A Astatine Reproducibility of Results erbB-2) EC 2-7-1-112 (Receptor Genetic Therapy Rats Camptothecin Cell Communication Cisplatin Drug Delivery Systems Optical Imaging Antisense Oligodeoxyribonucleotides Fibroblasts aa [Analogs & Derivatives] Isothiocyanates 0 (Yttrium Radioisotopes) Non-US Gov't Research Support NF-kappa B Peptide Fragments DNA Primers Hep G2 Cells Nanoparticle extravasation Proto-Oncogene Proteins p21(ras) Small Molecule Libraries P-Glycoprotein Fibroblast Growth Factor Receptors Tissue Culture Pentetic Acid Oligonucleotide Array Sequence Analysis Gamma Rays Ubiquitin-Protein Ligases Animal Disease Models deficiency Aminopyridines Anilides Genetic Vectors Pyridazines Young Adult Proto-Oncogene Proteins c-bcl-2 Immunoglobulin Fragments Yttrium Radioisotopes Intravital microscopy Pyrroles HGF Hemangiosarcoma DNA-Binding Proteins therapy Liver cancer stem-like cells Cellular Spheroids Nanoparticles Drug Carriers Phosphorylation Inhibitory Concentration 50 Nanodroplets Colonic Neoplasms Polycomb Repressive Complex 2 Cerulenin Bismuth Capillary Electrophoresis Cell Division Polymers Nanoparticle diffusion Cell Survival Perfluorocarbon Nk4 ATP-Binding Cassette Transporters ad [Administration & Dosage] Sulfones Drug delivery Prognosis Multidrug resistance
Last updated on Wednesday, February 05, 2020